Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,983 | -32,114 | -18,356 | -7,435 | -15,040 |
| Depreciation Amortization | 216 | 168 | 101 | 39 | 150 |
| Accounts payable and accrued liabilities | 1,007 | 356 | 1,864 | 724 | 388 |
| Other Working Capital | 2,277 | -1,564 | -1,187 | -635 | 2,308 |
| Other Operating Activity | 3,607 | 2,951 | -208 | -19 | -6,430 |
| Operating Cash Flow | $-42,876 | $-30,203 | $-17,786 | $-7,326 | $-18,624 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -498 | -226 | -124 | -13 | -560 |
| Investing Cash Flow | $-498 | $-226 | $-124 | $-13 | $-560 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 111,805 | 111,779 | 111,752 | 21 | 26 |
| Other Financing Activity | -2,378 | -2,390 | -2,087 | -559 | 93,831 |
| Financing Cash Flow | $109,427 | $109,389 | $109,665 | $-538 | $93,857 |
| Beginning Cash Position | 92,777 | 92,777 | 92,777 | 92,777 | 18,104 |
| End Cash Position | 158,830 | 171,737 | 184,532 | 84,900 | 92,777 |
| Net Cash Flow | $66,053 | $78,960 | $91,755 | $-7,877 | $74,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,876 | -30,203 | -17,786 | -7,326 | -18,624 |
| Capital Expenditure | -498 | -226 | -124 | -13 | -560 |
| Free Cash Flow | -43,374 | -30,429 | -17,910 | -7,339 | -19,184 |